Description
For Research Purposes Only. Not approved for human consumption. Tirzepatide Research Peptide Tirzepatide is a synthetic dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed by Eli Lilly — the first-in-class twincretin peptide. In Phas






Reviews
There are no reviews yet.